Literature DB >> 9653174

Evidence for multiclonality in multicentric Kaposi's sarcoma.

P S Gill1, Y C Tsai, A P Rao, C H Spruck, T Zheng, W A Harrington, T Cheung, B Nathwani, P A Jones.   

Abstract

Kaposi's sarcoma (KS) develops in a variety of clinical states and is the most common tumor seen in patients with HIV-1 infection. KS develops as a multifocal mucocutaneous disease with subsequent spread to visceral organs, and it has been argued to be a benign proliferation caused by its multifocality at initial presentation, lack of aneuploidy, and spontaneous regression upon withdrawal of immunosuppressive agents in iatrogenically induced disease. We wished to determine whether KS lesions are clonal, indicative of a true neoplasm. Also, we tested whether multifocal KS lesions are clonally related, derived from a common progenitor cell or of independent cellular origin. We studied the X-chromosome inactivation pattern of the human androgen receptor gene in tumor biopsies of women with KS. This procedure tests for the clonality of a tissue specimen, a hallmark of neoplasia. Each specimen was microdissected to minimize normal cell contamination. Of 12 evaluable cases, 10 were HIV-seropositive and 2 were HIV-seronegative. Twenty-four biopsies from the 12 patients were examined. Five cases were consistent with individual KS lesions being clonal. In two cases, multiple KS specimens derived from the individual patients had different androgen receptor alleles inactivated, proving unequivocally that these KS lesions arose independently from distinct transformed cells. In seven cases, only a polyclonal pattern of inactivation was observed, whereas two others had tumor areas of both clonal and polyclonal inactivation patterns. These findings suggest that KS can be a clonal neoplasm, and in some of the cases multiple KS lesions in a given patient can arise from independent cellular origins and acquire clonal characteristics. The polyclonal inactivation pattern observed in other KS lesions may represent a premalignant stage or false negative results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653174      PMCID: PMC20963          DOI: 10.1073/pnas.95.14.8257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  P Delli Bovi; E Donti; D M Knowles; A Friedman-Kien; P A Luciw; D Dina; R Dalla-Favera; C Basilico
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

2.  Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).

Authors:  P S Gill; C Loureiro; M Bernstein-Singer; M U Rarick; F Sattler; A M Levine
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

3.  Clonal analysis using recombinant DNA probes from the X-chromosome.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; A C Preisinger; H F Willard; A M Michelson; A D Riggs; S H Orkin
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

4.  Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection.

Authors:  B Siegal; S Levinton-Kriss; A Schiffer; J Sayar; I Engelberg; A Vonsover; Y Ramon; E Rubinstein
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

5.  Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2.

Authors:  T A Waldmann; C K Goldman; K F Bongiovanni; S O Sharrow; M P Davey; K B Cease; S J Greenberg; D L Longo
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

6.  Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors.

Authors:  A R Lifson; W W Darrow; N A Hessol; P M O'Malley; J L Barnhart; H W Jaffe; G W Rutherford
Journal:  Am J Epidemiol       Date:  1990-02       Impact factor: 4.897

Review 7.  The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.

Authors:  A Wahman; S L Melnick; F S Rhame; J D Potter
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

8.  Steroid-related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma.

Authors:  F X Real; S E Krown; B Koziner
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

9.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

10.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

View more
  30 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 4.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

5.  Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.

Authors:  Ryota Nakayama; Yumiko Ueno; Keiji Ueda; Tomoyuki Honda
Journal:  Oncogene       Date:  2019-02-15       Impact factor: 9.867

Review 6.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Authors:  Zhiqiang Qin; Eduardo Freitas; Roger Sullivan; Sarumathi Mohan; Rocky Bacelieri; Drake Branch; Margaret Romano; Patricia Kearney; Jim Oates; Karlie Plaisance; Rolf Renne; Johnan Kaleeba; Chris Parsons
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

8.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 9.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  The malignant potential of HIV-associated Kaposi sarcoma.

Authors:  Neil H Wood; Liviu Feller
Journal:  Cancer Cell Int       Date:  2008-10-31       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.